Subsequently, we determined the prognostic value of variables in the risk model, and found that Z-DNA binding protein 1 (ZBP1) and FADD were candidate prognostic biomarkers for HNSCC (Fig. 1H). This evidence concerns the gene ZBP1 and head and neck squamous cell carcinoma.